Literature DB >> 26224867

C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death.

Daniel Kanmert1, Adam Cantlon2, Christina R Muratore1, Ming Jin1, Tiernan T O'Malley1, Gloria Lee3, Tracy L Young-Pearse1, Dennis J Selkoe1, Dominic M Walsh4.   

Abstract

Recent evidence suggests that tau aggregation may spread via extracellular release and subsequent uptake by synaptically connected neurons, but little is known about the processes by which tau is released or the molecular forms of extracellular tau. To gain insight into the nature of extracellular tau, we used highly sensitive ELISAs, which, when used in tandem, are capable of differentiating between full-length (FL) tau, mid-region-bearing fragments, and C-terminal (CT) fragments. We applied these assays to the systematic study of the conditioned media of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary rat cortical neurons, each of which was carefully assessed for viability. In all three neuronal models, the bulk of extracellular tau was free-floating and unaggregated and <0.2% was encapsulated in exosomes. Although most intracellular tau was FL, the majority of extracellular tau was CT truncated and appeared to be released both actively by living neurons and passively by dead cells. In contrast, only a small amount of extracellular tau was aggregation-competent tau (i.e., contained the microtubule-binding regions) and this material appears to be released solely due to a low level of cell death that occurs in all cell culture systems. Importantly, amyloid β-protein (Aβ)-induced neuronal compromise significantly increased the quantity of all forms of extracellular tau, but the presence of Aβ before detectable cell compromise did not increase extracellular tau. Collectively, these results suggest that factors that induce neuronal death are likely to be necessary to initiate the extracellular spread of tau aggregation. SIGNIFICANCE STATEMENT: Recent studies suggest that the transfer of tau between neurons underlies the characteristic spatiotemporal progression of neurofibrillary pathology. We searched for tau in the conditioned medium of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary rat cortical neurons and analyzed the material present using four different tau ELISAs. We demonstrate that the majority of tau released from healthy neurons is C-terminally truncated and lacks the microtubule-binding region (MTBR) thought necessary for self-aggregation. A small amount of MTBR-containing tau is present outside of cells, but this appears to be solely due to cell death. Therefore, if propagation of tau aggregation is mediated by extracellular tau, our findings suggest that neuronal compromise is required to facilitate this process.
Copyright © 2015 the authors 0270-6474/15/3510852-15$15.00/0.

Entities:  

Keywords:  ELISA; exosomes; neurons; secretion; tau

Mesh:

Substances:

Year:  2015        PMID: 26224867      PMCID: PMC6605107          DOI: 10.1523/JNEUROSCI.0387-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.

Authors:  Stefan Barghorn; Peter Davies; Eckhard Mandelkow
Journal:  Biochemistry       Date:  2004-02-17       Impact factor: 3.162

2.  The formation of straight and twisted filaments from short tau peptides.

Authors:  Warren J Goux; Lauren Kopplin; Anh D Nguyen; Kathryn Leak; Marni Rutkofsky; Vasanthi D Shanmuganandam; Deepak Sharma; Hideyo Inouye; Daniel A Kirschner
Journal:  J Biol Chem       Date:  2004-04-20       Impact factor: 5.157

3.  Solution state characterization of amyloid beta-derived diffusible ligands.

Authors:  Robert W Hepler; Karen M Grimm; Deborah D Nahas; Robert Breese; Elizabeth Chen Dodson; Paul Acton; Paul M Keller; Mark Yeager; Hui Wang; Paul Shughrue; Gene Kinney; Joseph G Joyce
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

4.  Culturing hippocampal neurons.

Authors:  Stefanie Kaech; Gary Banker
Journal:  Nat Protoc       Date:  2007-01-11       Impact factor: 13.491

5.  Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

Authors:  Clotilde Théry; Sebastian Amigorena; Graça Raposo; Aled Clayton
Journal:  Curr Protoc Cell Biol       Date:  2006-04

6.  Assessment of cell viability in primary neuronal cultures.

Authors:  Mandar A Aras; Karen A Hartnett; Elias Aizenman
Journal:  Curr Protoc Neurosci       Date:  2008-07

7.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

8.  Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro.

Authors:  Stefan Barghorn; Jacek Biernat; Eckhard Mandelkow
Journal:  Methods Mol Biol       Date:  2005

9.  Characterization of tau in cerebrospinal fluid using mass spectrometry.

Authors:  Erik Portelius; Sara F Hansson; Ai Jun Tran; Henrik Zetterberg; Pierre Grognet; Eugeen Vanmechelen; Kina Höglund; Gunnar Brinkmalm; Ann Westman-Brinkmalm; Eckhard Nordhoff; Kaj Blennow; Johan Gobom
Journal:  J Proteome Res       Date:  2008-03-20       Impact factor: 4.466

10.  Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

Authors:  C Hesse; L Rosengren; E Vanmechelen; H Vanderstichele; C Jensen; P Davidsson; K Blennow
Journal:  J Alzheimers Dis       Date:  2000-11       Impact factor: 4.472

View more
  63 in total

Review 1.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

Review 3.  Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.

Authors:  Garrett S Gibbons; Virginia M Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 4.  A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  Nat Rev Neurosci       Date:  2016-04       Impact factor: 34.870

5.  Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.

Authors:  Zhicheng Chen; David Mengel; Ashvini Keshavan; Robert A Rissman; Andrew Billinton; Michael Perkinton; Jennifer Percival-Alwyn; Aaron Schultz; Michael Properzi; Keith Johnson; Dennis J Selkoe; Reisa A Sperling; Purvish Patel; Henrik Zetterberg; Douglas Galasko; Jonathan M Schott; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2018-11-09       Impact factor: 21.566

6.  AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.

Authors:  A Borreca; V Latina; V Corsetti; S Middei; S Piccinin; F Della Valle; R Bussani; M Ammassari-Teule; R Nisticò; P Calissano; G Amadoro
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

7.  Structural characterization of monoclonal antibodies targeting C-terminal Ser404 region of phosphorylated tau protein.

Authors:  Jessica E Chukwu; Erin E Congdon; Einar M Sigurdsson; Xiang-Peng Kong
Journal:  MAbs       Date:  2019-02-26       Impact factor: 5.857

8.  Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo.

Authors:  Tomas Ondrejcak; Igor Klyubin; Grant T Corbett; Graham Fraser; Wei Hong; Alexandra J Mably; Matthew Gardener; Jayne Hammersley; Michael S Perkinton; Andrew Billinton; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

9.  Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Authors:  H Eric Feinstein; Sarah J Benbow; Nichole E LaPointe; Nirav Patel; Srinivasan Ramachandran; Thanh D Do; Michelle R Gaylord; Noelle E Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T Bowers; Ratnesh Lal; Stuart C Feinstein
Journal:  J Neurochem       Date:  2016-04-20       Impact factor: 5.372

Review 10.  Potential mechanisms and implications for the formation of tau oligomeric strains.

Authors:  Julia E Gerson; Amrit Mudher; Rakez Kayed
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.